AEON icon

AEON Biopharma

30 hedge funds and large institutions have $10.1M invested in AEON Biopharma in 2024 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
30
Holders Change
+6
Holders Change %
+25%
% of All Funds
0.43%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
14
Increased
4
Reduced
4
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
TRCT
26
Tower Research Capital (TRC)
New York
$5.52K +$151 +2 +3%
CIBC Private Wealth Group
27
CIBC Private Wealth Group
Georgia
$2.54K +$2.54K +34 New
Morgan Stanley
28
Morgan Stanley
New York
$1.89K
GIA
29
GHP Investment Advisors
Colorado
$1.15K
JPMorgan Chase & Co
30
JPMorgan Chase & Co
New York
$61 +$61 +1 New
DKCM
31
Davidson Kempner Capital Management
New York
-$94.6K -1,251 Closed
Millennium Management
32
Millennium Management
New York
-$53.5K -708 Closed
YIH
33
Y-Intercept (HK)
Hong Kong
-$22K -291 Closed
KL
34
KIM LLC
Kansas
-$16.3K -216 Closed
CL
35
CSS LLC
Illinois
-$12.7K -169 Closed
Goldman Sachs
36
Goldman Sachs
New York
-$11.9K -157 Closed
Qube Research & Technologies (QRT)
37
Qube Research & Technologies (QRT)
United Kingdom
-$1.11K -15 Closed